Xiu-juan Liang
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Survival Nomogram for Stage IV (M1a-c) Melanoma: A Population-Based Study Highlighting the Prognostic Correlates of Surgery in Pre-Immunotherapy and Early Immunotherapy Eras.
Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research
Published: July 14, 2026
Association of primary lesion surgery and surgical modality with overall survival in patients with stage IV cutaneous melanoma: a population-based study.
Journal: Translational cancer research
Published: February 08, 2026
The role of PD-L1 in patients with non-small cell lung cancer receiving neoadjuvant immune checkpoint inhibitor plus chemotherapy: a meta-analysis.
Journal: Scientific reports
Published: July 06, 2024
PD-L1 Expression and Its Prognostic Value in Different Tumor Specimens in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2024
Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 07, 2024
Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trial.
Journal: Lancet (London, England)
Published: December 15, 2023
Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma.
Journal: The Lancet. Oncology
Published: April 06, 2023
Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: March 30, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026